HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 26th at 1:00 pm ET. A webcast of the presentation will be available on the “Events & Presentations” page of the “Investors & Media” section of the Celldex website. A replay will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
The latest data release from the Commodity Futures Trading Commission (CFTC) reveals a marginal improvement…
Traders and economists are taking a keen interest in the latest update from the Commodity…
In an updated report dated April 18, 2025, the Commodity Futures Trading Commission (CFTC) has…
The Commodity Futures Trading Commission (CFTC) has reported an improvement in wheat speculative net positions…
In its latest release, the U.S. Commodity Futures Trading Commission (CFTC) reported a decrease in…
Amid market turmoil, will Bitcoin keep going up or is it due for another correction?…
This website uses cookies.